Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Observational studies suggested an association between diabetes and the risk of various geriatric conditions (i.e., cognitive impairment, dementia, depression, mobility impairment, disability, falls, and urinary incontinence). However, the magnitude and impact of diabetes on older adults have not been reviewed. METHODOLOGY/PRINCIPAL FINDINGS: MEDLINE and PSYCINFO databases were searched through November 2007 for published studies, supplemented by manual searches of bibliographies of key articles. Population-based, prospective cohort studies that reported risk of geriatric outcomes in relation to diabetes status at baseline were selected. Two authors independently extracted the data, including study population and follow-up duration, ascertainment of diabetes status at baseline, outcomes of interest and their ascertainment, adjusted covariates, measures of association, and brief results. Fifteen studies examined the association of DM with cognitive dysfunction. DM was associated with a faster decline in cognitive function among older adults. The pooled adjusted risk ratio (RR) for all dementia when persons with DM were compared to those without was 1.47 (95% CI, 1.25 to 1.73). Summary RRs for Alzheimer's disease and vascular dementia comparing persons with DM to those without were 1.39 (CI, 1.16 to 1.66) and 2.38 (CI, 1.79 to 3.18), respectively. Four of 5 studies found significant association of DM with faster mobility decline and incident disability. Two studies examined the association of diabetes with falls in older women. Both found statistically significant associations. Insulin users had higher RR for recurrent falls. One study for urinary incontinence in older women found statistically significant associations. Two studies for depression did not suggest that DM was an independent predictor of incident depression. CONCLUSIONS/SIGNIFICANCE: Current evidence supports that DM is associated with increased risk for selected geriatric conditions. Clinicians should increase their awareness and provide appropriate care. Future research is required to elucidate the underlying pathological pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“(3) patients at low risk for dementia (young mean age)441,445 and with high baseline MMSE;”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“(2) heterogeneity in screening and diagnosis of dementia441;”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alzheimer’s-type and multi-infarct dementia are approximately twice as likely to occur in those with diabetes compared to age-matched non-diabetic controls59.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [59]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Four of these trials reported that treatment had no clear-cut effect on the risk of dementia440,441,443,444 or cognitive function.441,443,444”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Four of these trials reported that treatment had no clear-cut effect on the risk of dementia440,441,443,444 or cognitive function.441,443,444”
From Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (2011) · cites this paper as [441]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339 · cited 2×
“Several molecular mechanisms have been proposed to explain the mediation between DM and hyperglycemia-induced tissue damage, including the advanced glycation end products (AGEs) [62].”
BackgroundEconomic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Zhang, J., & Yu, K. F. (1998) · JAMA · doi:10.1001/jama.280.19.1690 · Cited by 4,138 · cited 1×
“The adjusted odds ratios (ORs) were considered as RRs since the incidence of dementia were not common in the study population [46].”
BackgroundThe Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926 · cited 1×
“A few systematic reviews have focused on the effect of diabetes on individual geriatric outcomes [28,29], but they also presented several weaknesses, such as inclusion of cross-sectional studies or those without proper adjustment for major confounders.”
BackgroundDiabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Research works printed but not linked: 3
- SL Jackson, 2005, Urinary incontinence and diabetes in postmenopausal women., Diabetes Care, 28, 1730, 10.2337/diacare.28.7.1730 · DOI
- MS Maurer, 2005, Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility., J Gerontol A Biol Sci Med Sci, 60, 1157, 10.1093/gerona/60.9.1157 · DOI · Paper page
- JH Wu, 2003, Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study., Diabetes Care, 26, 314, 10.2337/diacare.26.2.314 · DOI
Cited by
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
“For example, in studies without biomarkers, diabetes has been claimed to be a risk factor for probable AD, when AD was defined as an amnestic dementia [215].”
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Potential for primary prevention of Alzheimer's disease: an analysis of population-based data
Norton, S., Matthews, F. E., Barnes, D. E., Yaffe, K., & Brayne, C. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70136-x · Cited by 2,466
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., & Johns, H. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.016 · Cited by 1,660
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
“Alzheimer’s-type and multi-infarct dementia are approximately twice as likely to occur in those with diabetes compared with age-matched nondiabetic control subjects (59).”
BackgroundThe burden and risks of emerging complications of diabetes mellitus
Tomic, D., Shaw, J. E., & Magliano, D. J. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00690-7 · Cited by 1,163
Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) International Consensus Group
Kelaiditi, E., Cesari, M., Canevelli, M., Abellan van Kan, G., Ousset, P.-J., Gillette-Guyonnet, S., Ritz, P., Duveau, F., Soto, M. E., Provencher, V., et al. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0367-2 · Cited by 1,084
“…studies have indicated that frailty was associated with low cognitive performance over time in older individuals with and without dementia (61-67) and cross-sectional analyses, although limited, have also reported associations between physical frailty and cognitive decline (68, 69). in…”
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline
Debette, S., Seshadri, S., Beiser, A., Au, R., Himali, J. J., Palumbo, C., Wolf, P. A., & DeCarli, C. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b227 · Cited by 772
Plassman, B. L., Williams, J. W., Burke, J. R., Holsinger, T., & Benjamin, S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-3-201008030-00258 · Cited by 681
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
The changing face of diabetes complications
Gregg, E. W., Sattar, N., & Ali, M. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30010-9 · Cited by 612
Drug treatments in Alzheimer’s disease
Briggs, R., Kennelly, S. P., & O’Neill, D. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-247 · Cited by 571
Deckers, K., van Boxtel, M. P. J., Schiepers, O. J. G., de Vugt, M., Muñoz Sánchez, J. L., Anstey, K. J., Brayne, C., Dartigues, J.-F., Engedal, K., Kivipelto, M., et al. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4245 · Cited by 534
“In a meta-analysis of six prospective studies, diabetes carried a 47% increased risk of dementia (Lu et al., 2009).”
Epidemiology of Dementias and Alzheimer’s Disease
Sosa-Ortiz, A. L., Acosta-Castillo, I., & Prince, M. J. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.11.003 · Cited by 553
Diabetes in Older Adults: A Consensus Report
Sue Kirkman, M., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12035 · Cited by 548
Oxidative stress and diabetes: antioxidative strategies
Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., & Zhang, Y. (2020) · Frontiers of Medicine · doi:10.1007/s11684-019-0729-1 · Cited by 513
Gregg, E. W., Cheng, Y. J., Srinivasan, M., Lin, J., Geiss, L. S., Albright, A. L., & Imperatore, G. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30314-3 · Cited by 480
Diabetes and risk of physical disability in adults: a systematic review and meta-analysis
Wong, E., Backholer, K., Gearon, E., Harding, J., Freak-Poli, R., Stevenson, C., & Peeters, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70046-9 · Cited by 470
A major role for cardiovascular burden in age-related cognitive decline
Qiu, C., & Fratiglioni, L. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.223 · Cited by 398
Hersi, M., Irvine, B., Gupta, P., Gomes, J., Birkett, N., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.03.006 · Cited by 332
“Eight moderate quality systematic reviews reported on the association between diabetes mellitus (DM) and risk of AD (Cukierman et al., 2005; Biessels et al., 2006; Weih et al., 2007; Patterson et al., 2007; Kloppenborg et al., 2008; Lu et al., 2009; Profenno et al., 2010; Williams et al., 2010).”
BackgroundAmerican Geriatrics Society Expert Panel on the Care of Older Adults with Diabetes Mellitus (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12514 · Cited by 326
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 304
Kalaria, R. N. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00352.x · Cited by 290
Kowalski, M. H., Qian, H., Hou, Z., Rosen, J. D., Tapia, A. L., Shan, Y., Jain, D., Argos, M., Arnett, D. K., Avery, C., et al. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008500 · Cited by 277
“evaluation through MEGA array genotyping in HCHS/SOL (in contrast to the availability of nearly all segregating variants in JHS through high coverage sequencing); and (3) the smaller number of relevant haplotypes in the TOPMed freeze 5b reference (~26% self-identified AAs”
BackgroundFrailty and sarcopenia - newly emerging and high impact complications of diabetes
Sinclair, A. J., Abdelhafiz, A. H., & Rodríguez-Mañas, L. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.003 · Cited by 276
Effects of diabetes on hippocampal neurogenesis: Links to cognition and depression
Ho, N., Sommers, M. S., & Lucki, I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.010 · Cited by 246
Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
Kaludercic, N., & Di Lisa, F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00012 · Cited by 263
Neuroinflammation and neurodegeneration in overnutrition-induced diseases
Cai, D. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.11.003 · Cited by 256
Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science
Daviglus, M. L., Plassman, B. L., Pirzada, A., Bell, C. C., Bowen, P. E., Burke, J. R., Connolly, E. S., Dunbar-Jacob, J. M., Granieri, E. C., McGarry, K., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.100 · Cited by 252
Munshi, M. N., Florez, H., Huang, E. S., Kalyani, R. R., Mupanomunda, M., Pandya, N., Swift, C. S., Taveira, T. H., & Haas, L. B. (2016) · Diabetes Care · doi:10.2337/dc15-2512 · Cited by 243
“microvascular complications but also increases the risk of common geriatric syndromes, including cognitive impairment, depression, falls, polypharmacy, persistent pain, and urinary incontinence (7,8).”
BackgroundDiabetes Mellitus and Dementia
Ninomiya, T. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0487-z · Cited by 212
“Nevertheless, current evidence from randomized control trials, few of which were conducted in people with diabetes mellitus, suggest that the standard strategies of cardiovascular risk reduction (eg, anti-hypertensive agents, anti-platelet therapy, and statin treatment) among elderly populations are not effective in r…”
InfluentialAnstey, K. J., Cherbuin, N., & Herath, P. M. (2013) · Prevention Science · doi:10.1007/s11121-012-0313-2 · Cited by 207
“No diabetes Reference 0 Lu et al. 2009 Diabetes 0.33 3”
BackgroundInfluentialKaton, W., Pedersen, H. S., Ribe, A. R., Fenger-Grøn, M., Davydow, D., Waldorff, F. B., & Vestergaard, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0082 · Cited by 202
An update on type 2 diabetes, vascular dementia and Alzheimer’s disease.
Exalto, L. G., Whitmer, R. A., Kappele, L. J., & Biessels, G. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.014 · Cited by 194
“A downside of this improved longevity is an increased risk of geriatric health complications, including cognitive impairment and dementia (Lu et al., 2009; Strachan et al., 2011).”
BackgroundAnstey, K. J., Ee, N., Eramudugolla, R., Jagger, C., & Peters, R. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190181 · Cited by 187
“Lu 2009 [15] Type II diabetes (medical history, laboratory test, antidiabetic medications) LL 1.”
BackgroundFeinkohl, I., Price, J. F., Strachan, M. W. J., & Frier, B. M. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0130-5 · Cited by 182
“disease (AD) and vascular dementia (VaD), both in the general population [1] and in people who have already been diagnosed with a milder form of age-related cognitive impairment (mild cognitive impairment) [2].”
BackgroundRisk factors for dementia with Lewy bodies: A case-control study
Boot, B. P., Orr, C. F., Ahlskog, J. E., Ferman, T. J., Roberts, R., Pankratz, V. S., Dickson, D. W., Parisi, J., Aakre, J. A., Geda, Y. E., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a2cbd1 · Cited by 173
Microvascular Dysfunction and Cognitive Impairment
De Silva, T. M., & Faraci, F. M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0308-1 · Cited by 171
“Diabetes and hyperhomocysteinemia, additional cardiovascular risk factors, are also risk factors for cognitive decline (Kamat et al. 2015; Lu et al. 2009; Maron and Loscalzo 2009).”
BackgroundType 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis
Cheng, C., Lin, C.-H., Tsai, Y.-W., Tsai, C.-J., Chou, P.-H., & Lan, T.-H. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu073 · Cited by 167
Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
Cereda, E., Barichella, M., Cassani, E., Caccialanza, R., & Pezzoli, G. (2012) · Neurology · doi:10.1212/wnl.0b013e3182553cc9 · Cited by 166
Development and validation of a brief dementia screening indicator for primary care
Barnes, D. E., Beiser, A. S., Lee, A., Langa, K. M., Koyama, A., Preis, S. R., Neuhaus, J., McCammon, R. J., Yaffe, K., Seshadri, S., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.11.006 · Cited by 162
Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes
Moulton, C. D., Costafreda, S. G., Horton, P., Ismail, K., & Fu, C. H. Y. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-014-9348-2 · Cited by 161
“New Old Pathologies”: AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS)
Nelson, P. T., Trojanowski, J. Q., Abner, E. L., Al-Janabi, O. M., Jicha, G. A., Schmitt, F. A., Smith, C. D., Fardo, D. W., Wang, W.-X., Kryscio, R. J., et al. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw033 · Cited by 158
Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia
Wang, F., Cao, Y., Ma, L., Pei, H., Rausch, W. D., & Li, H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00376 · Cited by 157
Effects of Type 2 Diabetes on 12-Year Cognitive Change
Spauwen, P. J. J., Köhler, S., Verhey, F. R. J., Stehouwer, C. D. A., & van Boxtel, M. P. J. (2013) · Diabetes Care · doi:10.2337/dc12-0746 · Cited by 153
“Other putative factors include hyperglycemia, which can have toxic effects on the brain by glycation of important proteins (1,2), and insulin, which inhibits degradation of amyloid-b peptide (the main product of the Alzheimer’s disease process) by competition for insulin-degrading enzyme in the brain (1,2).”
Aging, Diabetes, and the Public Health System in the United States
Caspersen, C. J., Thomas, G. D., Boseman, L. A., Beckles, G. L. A., & Albright, A. L. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300616 · Cited by 150
Glucose indices are associated with cognitive and structural brain measures in young adults
Weinstein, G., Maillard, P., Himali, J. J., Beiser, A. S., Au, R., Wolf, P. A., Seshadri, S., & DeCarli, C. (2015) · Neurology · doi:10.1212/wnl.0000000000001655 · Cited by 149
Lyles, C. R. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.154 · Cited by 136
Adverse Effects of Depression on Glycemic Control and Health Outcomes in People with Diabetes
Pouwer, F., Nefs, G., & Nouwen, A. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.002 · Cited by 132
Sullivan, M. D., Katon, W. J., Lovato, L. C., Miller, M. E., Murray, A. M., Horowitz, K. R., Bryan, R. N., Gerstein, H. C., Marcovina, S., Akpunonu, B. E., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1965 · Cited by 132
“To ensure quality control, we (1) certified testers at baseline and semiannually thereafter, (2) reviewed a 10% random sample of tape recordings acquired during testing, (3) did random reviews comparing test forms with data entered into the database, and (4) checked test and tester score distributions for unusual tren…”
MethodRisk of Dementia in Seniors With Newly Diagnosed Diabetes: A Population-Based Study
Haroon, N. N., Austin, P. C., Shah, B. R., Wu, J., Gill, S. S., & Booth, G. L. (2015) · Diabetes Care · doi:10.2337/dc15-0491 · Cited by 126
Pijpers, E., Ferreira, I., de Jongh, R. T., Deeg, D. J. H., Lips, P. T. A. M., Stehouwer, C. D. A., & Kruseman, A. C. N. (2011) · Age and Ageing · doi:10.1093/ageing/afr145 · Cited by 136
Multi-domain interventions for the prevention of dementia and cognitive decline
Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013572.pub2 · Cited by 124
Update on cognitive decline and dementia in elderly patients with diabetes
Bordier, L., Doucet, J., Boudet, J. M., & Bauduceau, B. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.02.002 · Cited by 136
“Longitudinal studies in which diabetes and dementia, includng vascular dementia, Alzheimer’s disease (AD) and mixed orms of dementia, were assessed in later life have demontrated consistent results [5,12,14,15].”
BackgroundResultImaging transcriptomics of brain disorders
Arnatkeviciute, A., Fulcher, B. D., Bellgrove, M. A., & Fornito, A. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.10.002 · Cited by 113
“Type 2 diabetes (T2D) is associated with increased risk for AD (118).”
BackgroundInnes, K. E., Selfe, T. K., Khalsa, D. S., & Kandati, S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151106 · Cited by 123
“…of subsequent cognitive decline and progression to AD [4, 5, 34, 35, 39–51], with reported risk estimates similar to or greater than those for hypertension, diabetes, obesity, and other established risk factors [42, 52, 53], highlighting the importance of timely and effective intervention.”
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association
Lazar, R. M., Howard, V. J., Kernan, W. N., Aparicio, H. J., Levine, D. A., Viera, A. J., Jordan, L. C., Nyenhuis, D. L., Possin, K. L., Sorond, F. A., et al. (2021) · Stroke · doi:10.1161/str.0000000000000367 · Cited by 109
Genetic Variants in the Fat and Obesity Associated (FTO) Gene and Risk of Alzheimer's Disease
Reitz, C., Tosto, G., Mayeux, R. P., Luchsinger, J. A., & the NIA-LOAD/NCRAD Family Study Group and the Alzheimer's Disease Neuroimaging Initiative (2012) · PLoS ONE · doi:10.1371/journal.pone.0050354 · Cited by 119
“While for diabetes the association with AD seems clear [3,4], the association for most other cardiovascular risk factors, including obesity, remains largely inconsistent across studies.”
BackgroundParkinson's disease and Alzheimer disease: environmental risk factors
Campdelacreu, J. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.04.022 · Cited by 118
“39).(17) The Cardiovascular Health Study found a synergic effect with the APOE*4 allele such that risk of AD in patients with type 2 DM (DM2) and the APOE*4 allele was higher than for each separate risk factor.”
BackgroundLiao, J., Chao, T., Liu, C., Wang, K.-L., Chen, S., Tuan, T.-C., Lin, Y.-J., Chang, S., Lo, L.-W., Hu, Y.-F., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.170 · Cited by 111
“Several components of these 2 scoring schemes, such as an old age, hypertension, and diabetes, were reported to be important risk factors of dementia [9–11].”
BackgroundPrevention of Vascular Cognitive Impairment
Dichgans, M., & Zietemann, V. (2012) · Stroke · doi:10.1161/strokeaha.112.651778 · Cited by 107
Diabetes self-management programmes in older adults: A systematic review and meta-analysis
Sherifali, D., Bai, J. ‐., Kenny, M., Warren, R., & Ali, M. U. (2015) · Diabetic Medicine · doi:10.1111/dme.12780 · Cited by 102
Enfermedad de Parkinson y enfermedad de Alzheimer: factores de riesgo ambientales
Campdelacreu, J. (2012) · Neurología · doi:10.1016/j.nrl.2012.04.001 · Cited by 120
“…de EP en DM, uno no asociación y otro menor riesgo 1 En cuanto a la EA, hay evi-dencia de mayor riesgo en pacientes con DM y en sujetos con niveles altos de insulina incluso sin DM De 8 estudios prospectivos, en 3 se halló mayor riesgo de EA en DM y en 5 no asociación (RR combinado 1,39) 17 .”
Obesity-Induced Brain Neuroinflammatory and Mitochondrial Changes
Schmitt, L. O., & Gaspar, J. M. (2023) · Metabolites · doi:10.3390/metabo13010086 · Cited by 109
Kim, S., Sargent-Cox, K., Cherbuin, N., & Anstey, K. J. (2014) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000362228 · Cited by 101
Diabetes is associated with risk of postoperative cognitive dysfunction: A meta‐analysis
Feinkohl, I., Winterer, G., & Pischon, T. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2884 · Cited by 107
Insulin Promotes Neuronal Survival via the Alternatively Spliced Protein Kinase CδII Isoform
Apostolatos, A., Song, S., Acosta, S., Peart, M., Watson, J. E., Bickford, P., Cooper, D. R., & Patel, N. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313080 · Cited by 94
“Human studies and epidemiological data suggest a strong link between insulin and cognition (41).”
BackgroundDysregulation of parkin in the substantia nigra of db/db and high-fat diet mice
Khang, R., Park, C., & Shin, J.-H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.017 · Cited by 97
“Although there is still a great deal to be discovered, several mechanistic lines of evidence have suggested a close relationship between metabolic diseases and neurodegenerative diseases such as PD (Lees et al., 2009; Lu et al., 2009).”
Association between hypoglycemia and dementia in patients with type 2 diabetes
Sheen, Y., & Sheu, W. H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.004 · Cited by 105
“Cognitive impairment and dementia may significantly contribute to the impairment of many functions, increased risks of fall and fractures [13], enhanced depressive symptoms [14], and altered quality of life [3,4], and may be an independent predictor of clinical outcomes of T2DM patients [3,4,15].”
Diabetes Self-Care and the Older Adult
Weinger, K., Beverly, E. A., & Smaldone, A. M. (2014) · Western Journal of Nursing Research · doi:10.1177/0193945914521696 · Cited by 113
Insulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links
Ribe, E. M., & Lovestone, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12534 · Cited by 84
Rosso, A. L., Eaton, C. B., Wallace, R. B., Gold, R. B., Stefanick, M. L., Ockene, J. K., Curb, J. D., & Michael, Y. L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12147 · Cited by 107
“Geriatric syndromes may also occur as a result of a chronic disease or its treatment.(10,11) Geriatric syndromes arise from multifactorial impairments of bodily systems.”
BackgroundGunn‐Moore, D., Kaidanovich‐Beilin, O., Iradi, M. C. G., Gunn‐Moore, F., & Lovestone, S. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.08.014 · Cited by 83
Rodríguez-Mañas, L., Bayer, A. J., Kelly, M., Zeyfang, A., Izquierdo, M., Laosa, O., Hardman, T. C., & Sinclair, A. J. (2014) · Trials · doi:10.1186/1745-6215-15-34 · Cited by 80
“The worsening in functional status due to deterioration of skeletal muscle, increased co-morbidities, and adverse effects of overmedication associated with diabetes, results in many older frail people becoming more disabled, with an impaired quality of life associated with increased use of health care resources [6-8].”
BackgroundRaj, R., Kaprio, J. A., Korja, M., Mikkonen, E. D., Jousilahti, P., & Siironen, J. O. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002316 · Cited by 87
Associations of the metabolic syndrome and its components with cognitive impairment in older adults
Feinkohl, I., Janke, J., Hadzidiakos, D. A., Slooter, A. J. C., Winterer, G., Spies, C., & Pischon, T. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1073-7 · Cited by 84
Preventing Alzheimer's Disease by Targeting Vascular Risk Factors: Hope and Gap
Qiu, C. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120922 · Cited by 78
Mordarska, K., & Godziejewska-Zawada, M. (2017) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2017.68589 · Cited by 130
“It is generally known that postprandial hyperglycaemia starts to dominate with age, sometimes with correct fasting glucose level [12].”
BackgroundKuate Defo, A., Bakula, V., Pisaturo, A., Labos, C., Wing, S. S., & Daskalopoulou, S. S. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15331 · Cited by 75
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 85
Lu, C.-H., Yang, C., Li, C., Hsieh, C., & Ou, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4499-5 · Cited by 70
Developing Dementia-Capable Health Care Systems
Soo Borson, B., & Chodosh, J. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.05.001 · Cited by 78
Danna, S. M., Graham, E., Burns, R. J., Deschênes, S. S., & Schmitz, N. (2016) · PLOS ONE · doi:10.1371/journal.pone.0160809 · Cited by 67
“[4] For the purposes of this review, the use of the term “diabetes” will refer to all or unspecified types of diabetes unless otherwise noted.”
Herke, M., Fink, A. M., Langer, G., Wustmann, T., Watzke, S., Hanff, A.-M., & Burckhardt, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011542.pub2 · Cited by 82
Multi-domain interventions for the prevention of dementia and cognitive decline
Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013572 · Cited by 65
Zakaria, M. H. B., Davis, W. A., & Davis, T. M. E. (2013) · Diabetic Medicine · doi:10.1111/dme.12344 · Cited by 70
Impaired constitutive and regenerative neurogenesis in adult hyperglycemic zebrafish
Dorsemans, A.-C., Soulé, S., Weger, M., Bourdon, E., d’Hellencourt, C. L., Meilhac, O., & Diotel, N. (2016) · The Journal of Comparative Neurology · doi:10.1002/cne.24065 · Cited by 70
Impact of intensive lifestyle intervention on disability-free life expectancy: the Look AHEAD study
Gregg, E. W., Lin, J., Bardenheier, B., Chen, H., Rejeski, W. J., Zhuo, X., Hergenroeder, A. L., Kritchevsky, S. B., Peters, A. L., Wagenknecht, L. E., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2110 · Cited by 64
“strumental and basic activities of daily living (5,18,19).”
BackgroundCardiovascular risk factors and frontotemporal dementia: a case–control study
Golimstok, A., Cámpora, N., Rojas, J. I., Fernandez, M. C., Elizondo, C., Soriano, E., & Cristiano, E. (2014) · Translational Neurodegeneration · doi:10.1186/2047-9158-3-13 · Cited by 62
“Although these risk factors are well studied in Alzheimer’s Disease (AD), Vascular Dementia (VD) and Lewy Body Disease (LBD) [10-16], very few reports are found in FTD.”
BackgroundCigolle, C. T., Blaum, C. S., Lyu, C., Ha, J., Kabeto, M. U., & Zhong, J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.32766 · Cited by 74
Disability-Free Life-Years Lost Among Adults Aged ≥50 Years With and Without Diabetes
Bardenheier, B. H., Lin, J., Zhuo, X., Ali, M. K., Thompson, T. J., Cheng, Y. J., & Gregg, E. W. (2016) · Diabetes Care · doi:10.2337/dc15-1095 · Cited by 62
“Disability experienced among people with diabetes includes loss of mobility, and the ability to carry out instrumental and basic activities of daily living(3–6).”
Mobile Diabetes Intervention for Glycemic Control in 45- to 64-Year-Old Persons With Type 2 Diabetes
Quinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Park, D., Shaikh, F., Guralnik, J. M., & Gruber‐Baldini, A. L. (2014) · Journal of Applied Gerontology · doi:10.1177/0733464814542611 · Cited by 70
Ghouse, J., Isaksen, J. L., Skov, M. W., Lind, B., Svendsen, J. H., Kanters, J. K., OLESEN, M. S., Holst, A. G., & Nielsen, J. B. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13891 · Cited by 77
Shinohara, M., Sato, N., Shimamura, M., Kurinami, H., Hamasaki, T., Chatterjee, A., Rakugi, H., & Morishita, R. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00071 · Cited by 59
“A recent meta-analysis of 15 prospective cohort studies revealed that diabetes also increases the risk of AD (HR 1.39, 95% CI 1.16–1.66; Lu et al., 2009).”
InfluentialOptimal therapy of type 2 diabetes: a controversial challenge
Dardano, A., Penno, G., Prato, S. D., & Miccoli, R. (2014) · Aging · doi:10.18632/aging.100646 · Cited by 68
“Special thoughts for elderly patients affected by type 2 diabetes mellitus T2DM can be independently associated with various aging phenotypes collectively defined as “geriatric syndromes” [11,52-57].”
BackgroundDiabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine
Seto, S. W., Yang, G., Kiat, H., Bensoussan, A., Kwan, Y. W., & Chang, D. (2015) · International Journal of Endocrinology · doi:10.1155/2015/810439 · Cited by 64
“An increasing number of studies have reported an acceleration of cognitive decline in patients with DM, independent of common cardiovascular risk factors [8, 22].”
Background
Metadata
- Authors
- Lu, F.-P., Lin, K.-P., & Kuo, H.-K.
- Affiliations
- National Taiwan University (TW)
- National Health Research Institutes (TW)
- Corresponding author
- Kuo, Hsu-Ko
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-01-07
- Volume
- 4
- Issue
- 1
- Pages
- e4144
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2607544
- OpenAlex
- W1993533355
- Cited by
- 398
- References
- 83
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 16 · 2023: 21 · 2022: 14 · 2021: 13 · 2020: 20 · 2019: 19 · 2018: 26 · 2017: 36 · 2016: 27 · 2015: 45 · 2014: 40 · 2013: 37 · 2012: 29
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Health Research Institutes
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
- Keywords
- diabetes mellitus, geriatric conditions, cognitive impairment, dementia, Alzheimer's disease, vascular dementia, mobility decline, disability, falls, urinary incontinence, depression, insulin therapy, older adults
- MeSH terms
- Aging, Diabetes Mellitus, Type 2, Humans, Phenotype, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

